InvestorsHub Logo

caravon

02/08/16 5:27 PM

#199591 RE: DewDiligence #199590

Dew,

Please clarify: does ENTA's cash of $254.5 include or not $17.9M?

It is incredible that
- V-Pak is a multimi-B dollar drug and ENTA just gets a lousy &18M per Q. ENTA management is a big failure raising money and/or negotiating the partnership deals with ABT/ABBV. At the same time, the management did not forget paying themselves multimillion dollar compensation packages.
- For the last 10 years, ENTA components for V-Pak and Next-Gen are only successfully developed products.
- Taking into account the size of GILD's last Q sale in Japan, the next Q royalties for ENTA will get quite substantially higher royalties.
-ENTA's Market Cap is just $400M

PS
Is somebody coming to ENTA AM this Thursday?

masterlongevity

02/08/16 6:21 PM

#199593 RE: DewDiligence #199590

$enta. anything new or surprising in the report? IVe stopped looking at any news related to my portfolio because im trying to close my eyes until this death spiral is over

DewDiligence

05/09/16 7:04 PM

#201290 RE: DewDiligence #199590

ENTA had $245.6M of cash at 3/31/16 (a reduction of $8.9M relative to 12/31/15):

http://finance.yahoo.com/news/enanta-pharmaceuticals-reports-financial-results-200200117.html